Carvotroline

This classification denotes an antipsychotic agent with the molecular formula C18H18FN3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Q63WWP8G5, chemically known as 1h-pyrido(4,3-b)indole, 8-fluoro-2,3,4,5-tetrahydro-2-(2-(4-pyridinyl)ethyl)- but generally known as carvotroline, which bears US NIH Compound Identifier 72038. Carvotroline most often comes in base and hydrochloride forms. European Medicines Agency schedules Carvotroline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06154MIG. The term CARVOTROLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). CARVOTROLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carvotroline under HS 29333999 and SITC 51574. As of Q4 2014, CARVOTROLINE remains the US FDA Preferred Term for this commodity. Carvotroline bears US NLM identifiers UMLS ID C0668910 and NCI Concept Code C79946. SMILES: FC1CC2C3CN(CCC3[NH]C2CC1)CCC1CCNCC1.